ArticleEuropean heart journal. Imaging methods and practice2026
New CT-based dural ectasia criteria using machine learning to diagnose Marfan and Loeys-Dietz syndromes.
Article in European heart journal. Imaging methods and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Dural ectasia (DE) is a criterion for Marfan syndrome (MFS) diagnosis. However, there is no agreement on its diagnosis. We identified new DE criteria on CT-scan imaging using machine-learning (ML) and aimed to evaluate their performance for MFS and Loeys-Dietz detection. Methods and results: MFS patients with FBN1 pathogenic variant, who underwent a complete CT-scan were included and matched 1:1 with controls. The conventional criteria for DE were assessed, as well as new criteria identified by ML (generalized linear model and random forest), regarding MFS diagnostic performance. The new DE criteria were then evaluated for identification of Loeys-Dietz patients with TGFßR1/2 and SMAD3 pathogenic variants. A user-friendly online interface was finally developed to predict the probability of MFS or Loeys-Dietz diagnosis.Between November 2010 and January 2017, 93 MFS patients and their matched controls were included. Mean age was 39 ± 13 years with 45% of women. Conventional definitions of DE showed poor diagnostic performance for MFS: AUC 0.68 (0.61-0.74).The new DE criteria, based on simple CT-scan measurements (antero-posterior diameter of the spinal canal and scalloping) on vertebrae L1, L2 and S1, achieved AUC 0.84 (0.69-0.94). These criteria outperformed the Ghent-criteria for MFS diagnosis. Moreover, in 46 patients with TGFßR1/2 and 40 with SMAD3 pathogenic variants, the new criteria also achieved good diagnostic performance (AUC 0.83 (0.73-0.90) and 0.80 (0.70-0.88) respectively). Conclusion: New CT-scan DE criteria showed good performance for detecting MFS or Loeys-Dietz syndromes. Given the importance of early diagnosis, these new simple criteria offer a promising screening tool.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.